NCT01230294

Brief Summary

Aims of this study are the evaluation of new echocardiographic methods (3D/4D- and strain-echocardiography) for measurement of the right ventricular (RV) function .

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

October 28, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 29, 2010

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Last Updated

November 8, 2016

Status Verified

November 1, 2016

Enrollment Period

5.2 years

First QC Date

October 28, 2010

Last Update Submit

November 5, 2016

Conditions

Keywords

echocardiography of the right heart3D 4D echocardiographystrain measurementchronic heart failurepulmonary hypertension

Outcome Measures

Primary Outcomes (2)

  • 3D-volumetry of the right ventricle

    2 years

  • 2D strain of the right ventricle

    2 years

Secondary Outcomes (5)

  • pulmonary artery systolic pressure (PASP)

    2 years

  • tricuspid annular plane systolic excursion (TAPSE)

    2 years

  • tricuspid annular systolic velocity (TASV)

    2 years

  • Tei-index (myocardial performance index)

    2 years

  • LV-eccentricity-index (Lei-index)

    2 years

Study Arms (3)

control

participants without structural heart disease

CHF

patients with chronic heart failure of the left ventricle affecting the right heart

PAH

patients with pulmonary arterial hypertension without left ventricular dysfunction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* patients with pulmonary aterial hypertension * patients with chronic heart failure of the left ventricle affecting the right heart * patients without structural heart disease who underwent an echocardiographic examination for other reasons (control group)

You may qualify if:

  • persons of 18 years and older who receive a transthoracic echocardiography at our department
  • written consent

You may not qualify if:

  • present atrial fibrillation/flutter
  • permanent pacemaker rhythm
  • moderate/severe valvular heart disease
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Heidelberg

Heidelberg, Baden-Wurttemberg, 69120, Germany

Location

Related Publications (3)

  • Greiner S, Andre F, Heimisch M, Hess A, Steen H, Katus HA, Mereles D. Non-invasive quantification of right ventricular systolic function by echocardiography: a new semi-automated approach. Clin Res Cardiol. 2013 Mar;102(3):229-35. doi: 10.1007/s00392-012-0528-z. Epub 2012 Dec 4.

  • Greiner S, Goppelt F, Aurich M, Katus HA, Mereles D. Prognostic relevance of the right ventricular myo-mechanical index (RV-MMI) in patients with precapillary pulmonary hypertension. Open Heart. 2018 Sep 12;5(2):e000903. doi: 10.1136/openhrt-2018-000903. eCollection 2018.

  • Greiner S, Heimisch M, Aurich M, Hess JA, Katus HA, Mereles D. Multiplane two-dimensional strain echocardiography for segmental analysis of right ventricular mechanics: new-RV study. Clin Res Cardiol. 2014 Oct;103(10):817-24. doi: 10.1007/s00392-014-0723-1. Epub 2014 May 16.

MeSH Terms

Conditions

Ventricular Dysfunction, RightHypertension, Pulmonary

Condition Hierarchy (Ancestors)

Ventricular DysfunctionHeart DiseasesCardiovascular DiseasesLung DiseasesRespiratory Tract DiseasesHypertensionVascular Diseases

Study Officials

  • Sebastian Greiner, M.D.

    Heidelberg University

    PRINCIPAL INVESTIGATOR
  • Derliz Mereles, M.D.

    Heidelberg University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Derliz Mereles, M.D.

Study Record Dates

First Submitted

October 28, 2010

First Posted

October 29, 2010

Study Start

October 1, 2010

Primary Completion

December 1, 2015

Last Updated

November 8, 2016

Record last verified: 2016-11

Locations